SiPhox Health vs Alphabet Inc.
Side-by-side comparison of AI visibility scores, market position, and capabilities
MIT-founded home blood testing company measuring 17 biomarkers via mail-in kits; Khosla-backed developing photonic chip for instant at-home results competing with Everlywell.
About
SiPhox Health is a home blood testing company founded by MIT scientists that provides mail-in blood test kits measuring 17 key biomarkers — inflammation markers (CRP, homocysteine), cardiovascular health (LDL, HDL, triglycerides, ApoB), metabolic health (HbA1c, glucose, insulin), and hormone levels (testosterone, DHEA, cortisol) — with results delivered within days and integrated with an app for trend tracking and health guidance. Founded in 2020 by Diedrik Vermeulen and Michael Dubrovsky, SiPhox Health is backed by Khosla Ventures, Intel Capital, and Y Combinator.\n\nSiPhox's current product uses at-home finger-prick blood collection with mail-in testing — customers order a $95 kit, collect a small blood sample at home, and mail it to SiPhox's CLIA-certified lab for analysis. The $16/month membership provides regular testing on a quarterly or customizable schedule, enabling biomarker trend monitoring over time rather than single point-in-time snapshots. The underlying technology vision is a photonic chip (silicon photonics-based biosensor) that would enable instant at-home blood analysis without lab processing, with FDA clearance targeted for 2026.\n\nIn 2025, SiPhox Health competes in the home diagnostics and consumer health testing market with Everlywell (the leading at-home test kit brand), Function Health (comprehensive blood panel membership), InsideTracker, and traditional lab companies (LabCorp, Quest Diagnostics) for consumer blood testing. The longevity and proactive health monitoring movement has driven demand for comprehensive biomarker testing beyond what annual physicals provide. The potential photonic chip breakthrough would represent a significant technological leap — enabling truly point-of-care diagnostics without lab infrastructure. The 2025 strategy focuses on growing the biomarker panel subscription business, advancing the photonic chip development toward FDA clearance, and building clinical evidence for the personalized health intervention recommendations.
Mountain View AI and digital advertising conglomerate (NASDAQ: GOOGL) $350B FY2024 revenue (+15%); Google Search 90%+ share, Google Cloud $43.2B (+30%), Gemini AI, DOJ monopoly ruling 2024.
About
Alphabet Inc. is a Mountain View, California-based technology conglomerate — publicly traded on the NASDAQ (NASDAQ: GOOGL, GOOG) as an S&P 500 Information Technology component — operating as the holding company for Google (Search, YouTube, Google Ads, Gmail, Google Cloud, Android, Chrome, Maps, Play Store, Workspace), and Other Bets (Waymo autonomous vehicles, DeepMind AI research, Verily life sciences, Wing drone delivery, Google Fiber) through approximately 183,000 full-time employees. In fiscal year 2024, Alphabet reported revenues of $350 billion (+15% year-over-year), with Google Services (Search, YouTube, Google Play, subscriptions) generating $307 billion, Google Cloud generating $43.2 billion (+30%), and Other Bets $2.0 billion, while generating $100 billion in net income — reflecting Alphabet's position as one of the highest-profit companies in history, funded by Google Search's advertising monopoly (processing 8.5+ billion searches daily, commanding 90%+ global search market share). CEO Sundar Pichai has prioritized Alphabet's AI-first transformation: the 2024 launch of Gemini Ultra 1.0, Gemini 1.5 Pro (1 million token context window — largest at launch), and Gemini 2.0 Flash positioned Google as a competitive AI frontier model lab alongside OpenAI, following the ChatGPT disruption that temporarily threatened Google's search advertising dominance in 2023. Google Cloud's Vertex AI platform (enterprise AI model deployment with Gemini, Llama, and third-party models) and Google Distributed Cloud (air-gapped government cloud) compete directly with Microsoft Azure AI and AWS SageMaker for enterprise AI workload contracts. Waymo's commercial robotaxi operations in San Francisco, Phoenix, and Los Angeles (Waymo One — fully driverless rides, generating revenue and operational data) represent Alphabet's highest-upside long-duration investment.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.